FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247877832> ?p ?o ?g. }

• W4247877832 endingPage "3007" @default.
• W4247877832 startingPage "3001" @default.
• W4247877832 abstract "Ex vivo expanded peripheral blood progenitor cells (PBPCs) have been proposed as a source of hematopoietic support to decrease or eliminate the period of neutropenia after high-dose chemotherapy. CD34 cells were selected from rhG-CSF mobilized PBPCs from patients with breast cancer and were cultured for 10 days in defined media containing 100 ng/mL each of rhSCF, rhG-CSF, and PEG-rhMGDF in 1 L Teflon bags at 20 000 cells/mL. After culture the cells were washed and reinfused on day 0 of transplantation. On day +1, cohort 1 patients (n = 10) also received an unexpanded CD34-selected PBPC product. These patients engrafted neutrophils (absolute neutrophil count, >500/μL) in a median of 6 (range, 5-14) days. Cohort 2 patients (n = 11), who received expanded PBPCs only, engrafted neutrophils in a median of 8 (range, 4-16) days. In comparison, the median time to neutrophil engraftment in a historical control group of patients (n = 100) was 9 days (range, 7-30 days). All surviving patients are now past the 15-month posttransplantation stage with no evidence of late graft failure. The total number of nucleated cells harvested after expansion culture was shown to be the best predictor of time to neutrophil engraftment, with all patients receiving more than 4 × 107 cells/kg, engrafting neutrophils by day 8. No significant effect on platelet recovery was observed in any patient. These data demonstrate that PBPCs expanded under the conditions defined can shorten the time to engraftment of neutrophils compared with historical controls and that the rate of engraftment is related to the dose of expanded cells transplanted." @default.
• W4247877832 created "2022-05-12" @default.
• W4247877832 creator A5013882600 @default.
• W4247877832 creator A5014823276 @default.
• W4247877832 creator A5029237145 @default.
• W4247877832 creator A5035361443 @default.
• W4247877832 creator A5048724412 @default.
• W4247877832 creator A5049374615 @default.
• W4247877832 creator A5051544642 @default.
• W4247877832 creator A5055885795 @default.
• W4247877832 creator A5062058252 @default.
• W4247877832 creator A5068599434 @default.
• W4247877832 creator A5071526808 @default.
• W4247877832 creator A5073349656 @default.
• W4247877832 creator A5088237848 @default.
• W4247877832 creator A5090814068 @default.
• W4247877832 date "2000-11-01" @default.
• W4247877832 modified "2023-09-26" @default.
• W4247877832 title "Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer" @default.
• W4247877832 cites W1532162953 @default.
• W4247877832 cites W1881943990 @default.
• W4247877832 cites W1982583218 @default.
• W4247877832 cites W2006496100 @default.
• W4247877832 cites W2024837696 @default.
• W4247877832 cites W2040827928 @default.
• W4247877832 cites W2041310016 @default.
• W4247877832 cites W2125887123 @default.
• W4247877832 cites W2138917119 @default.
• W4247877832 cites W2151664626 @default.
• W4247877832 cites W2248120775 @default.
• W4247877832 cites W2270550164 @default.
• W4247877832 cites W2330713242 @default.
• W4247877832 cites W2333162405 @default.
• W4247877832 cites W2339456987 @default.
• W4247877832 cites W2419009192 @default.
• W4247877832 cites W4243529034 @default.
• W4247877832 cites W4244476964 @default.
• W4247877832 cites W4255083844 @default.
• W4247877832 doi "https://doi.org/10.1182/blood.v96.9.3001.h8003001_3001_3007" @default.
• W4247877832 hasPublicationYear "2000" @default.
• W4247877832 type Work @default.
• W4247877832 citedByCount "2" @default.
• W4247877832 crossrefType "journal-article" @default.
• W4247877832 hasAuthorship W4247877832A5013882600 @default.
• W4247877832 hasAuthorship W4247877832A5014823276 @default.
• W4247877832 hasAuthorship W4247877832A5029237145 @default.
• W4247877832 hasAuthorship W4247877832A5035361443 @default.
• W4247877832 hasAuthorship W4247877832A5048724412 @default.
• W4247877832 hasAuthorship W4247877832A5049374615 @default.
• W4247877832 hasAuthorship W4247877832A5051544642 @default.
• W4247877832 hasAuthorship W4247877832A5055885795 @default.
• W4247877832 hasAuthorship W4247877832A5062058252 @default.
• W4247877832 hasAuthorship W4247877832A5068599434 @default.
• W4247877832 hasAuthorship W4247877832A5071526808 @default.
• W4247877832 hasAuthorship W4247877832A5073349656 @default.
• W4247877832 hasAuthorship W4247877832A5088237848 @default.
• W4247877832 hasAuthorship W4247877832A5090814068 @default.
• W4247877832 hasConcept C10205521 @default.
• W4247877832 hasConcept C109159458 @default.
• W4247877832 hasConcept C126322002 @default.
• W4247877832 hasConcept C126894567 @default.
• W4247877832 hasConcept C141071460 @default.
• W4247877832 hasConcept C150903083 @default.
• W4247877832 hasConcept C201750760 @default.
• W4247877832 hasConcept C207001950 @default.
• W4247877832 hasConcept C26291073 @default.
• W4247877832 hasConcept C2776694085 @default.
• W4247877832 hasConcept C2776755627 @default.
• W4247877832 hasConcept C2777063308 @default.
• W4247877832 hasConcept C2777371436 @default.
• W4247877832 hasConcept C28328180 @default.
• W4247877832 hasConcept C2911091166 @default.
• W4247877832 hasConcept C54355233 @default.
• W4247877832 hasConcept C71924100 @default.
• W4247877832 hasConcept C74133956 @default.
• W4247877832 hasConcept C86803240 @default.
• W4247877832 hasConcept C90924648 @default.
• W4247877832 hasConceptScore W4247877832C10205521 @default.
• W4247877832 hasConceptScore W4247877832C109159458 @default.
• W4247877832 hasConceptScore W4247877832C126322002 @default.
• W4247877832 hasConceptScore W4247877832C126894567 @default.
• W4247877832 hasConceptScore W4247877832C141071460 @default.
• W4247877832 hasConceptScore W4247877832C150903083 @default.
• W4247877832 hasConceptScore W4247877832C201750760 @default.
• W4247877832 hasConceptScore W4247877832C207001950 @default.
• W4247877832 hasConceptScore W4247877832C26291073 @default.
• W4247877832 hasConceptScore W4247877832C2776694085 @default.
• W4247877832 hasConceptScore W4247877832C2776755627 @default.
• W4247877832 hasConceptScore W4247877832C2777063308 @default.
• W4247877832 hasConceptScore W4247877832C2777371436 @default.
• W4247877832 hasConceptScore W4247877832C28328180 @default.
• W4247877832 hasConceptScore W4247877832C2911091166 @default.
• W4247877832 hasConceptScore W4247877832C54355233 @default.
• W4247877832 hasConceptScore W4247877832C71924100 @default.
• W4247877832 hasConceptScore W4247877832C74133956 @default.
• W4247877832 hasConceptScore W4247877832C86803240 @default.
• W4247877832 hasConceptScore W4247877832C90924648 @default.
• W4247877832 hasIssue "9" @default.

• next